The authors explained the association between a low Hb level and poor prognosis in OPC patients as follows: low Hb concentration might exacerbate the preexisting hypoxia that is often present in tumors by decreasing oxygen-carrying capacity and so hampering the response of tumor cells to cytotoxic therapy [11]. The gene discussed is GSTM1; the disease is neoplasm.